Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder

BACKGROUND: This randomized, placebo-controlled, crossover trial examined the antidepressant efficacy of the muscarinic antagonist scopolamine in major depressive disorder subjects with more severe and refractory forms of major depressive disorder relative to previous reports. METHODS: Participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Lawrence, Furey, Maura, Nugent, Allison C, Farmer, Cristan, Ellis, Jessica, Szczepanik, Joanna, Lener, Marc S, Zarate, Carlos A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313153/
https://www.ncbi.nlm.nih.gov/pubmed/30184133
http://dx.doi.org/10.1093/ijnp/pyy051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313153/
https://www.ncbi.nlm.nih.gov/pubmed/30184133
http://dx.doi.org/10.1093/ijnp/pyy051

Ejemplares similares